​The MGH Interdisciplinary Brain Center (IBC) Game Pack: A Panel of Digital Games for Tracking Cognitive Functioning in Adults with Subjective Cognitive Complaints, Mild Cognitive Impairment, or Mild Dementia​

  • STATUS
    Recruiting
  • days left to enroll
    60
  • sponsor
    AbbVie
Send
Updated on 8 March 2023
See if I qualify
dementia
alzheimer's disease
cognitive decline
mild dementia

Summary

We have developed a new set of digital, tablet-based games, such as Solitaire and Tetris™, that we hope to use as a tool to monitor people’s memory and thinking abilities; particularly in people with cognitive decline, mild dementia, and Alzheimer's Disease. We believe that by capturing data about a person’s daily performance on these games can help us better understand cognitive functioning at least as well as traditional gold-standard, in-office neuropsychological assessments.

Description

Over a 6 month period, we will ask study participants to come in for 3 research visits and participate in 4 phone calls. Most research visits will involve cognitive testing and mood questionnaires. In between research visits, we will also ask participants to answer once-daily survey questions and complete at least 20 minutes of game play per day within the IBC Game Pack application. The consistent game play will allow us to understand more about how useful the IBC Game Pack is in better understanding cognition.

Details
Condition Dementia, Alzheimer's Disease, Mild Cognitive Impairment, Cognitive Decline
Clinical Study IdentifierTX310375
SponsorAbbVie
Last Modified on8 March 2023

Eligibility

 Yes No Not Sure

Inclusion Criteria

Participants with MCI or Alzheimer's need a study partner that can accompany them to every visit and co-sign documents
Education level of high school diploma or equivalent
Native English proficiency

Exclusion Criteria

Major active or chronic unstable psychiatric illness
History of alcohol or other substance abuse or dependence within the past two years
Discontinuation of cholinesterase inhibitor or memantine within 28 days of study participation
Additional exclusion criteria are up to the investigators discretion
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

dementia
alzheimer's disease
cognitive decline
mild dementia

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name
Edit Delete

Added by • 

 • 

Private

Edit Delete

Reply by • • Private
Edit Delete

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note